LONDON - Galapagos NV is to take over BioFocus plc in an all-share deal that values BioFocus at £20.2 million (US$37.8 million) or £1.24 per share, a 121 percent premium to the closing price of 56 pence the day before the deal was announced. (BioWorld International)

LONDON - Sandoz International filed a lawsuit against the FDA in a bid to force a ruling on the new drug application for Omnitrope, Sandoz's biogeneric form of recombinant human growth hormone. (BioWorld International)